Skip to content

The ThinkCancer! Feasibility Study

The ThinkCancer! Intervention: Protocol for a Feasibility Study Incorporating a Randomised Pilot Trial With an Embedded Process and Economic Evaluation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04823559
Enrollment
24
Registered
2021-04-01
Start date
2020-02-05
Completion date
2021-08-31
Last updated
2021-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Background Wales, like other UK countries, has relatively poor cancer outcomes. Late diagnosis and a slow referral process are major contributors. General practitioners (GPs) and other care providers working in primary care are often faced with patients presenting with a multitude of non-specific symptoms that could be cancer. Safety netting can be used to manage diagnostic uncertainty by ensuring patients with vague symptoms are appropriately monitored. The ThinkCancer! Workshop is an educational behaviour change intervention aimed at the whole general medical practice team, designed to improve primary care approaches to ensure timely diagnosis of cancer. The workshop will consist of teaching and awareness sessions, appointment of a Safety Netting Champion and the development of a bespoke Safety Netting Plan. This study aims to assess the feasibility of the ThinkCancer! Intervention for a future definitive randomised controlled trial, in terms of recruitment, randomisation, retention, acceptability, adherence and barriers to the intervention. Methods The ThinkCancer! study is a randomised, multisite feasibility trial, with an embedded process evaluation and economic evaluation. Twenty-three to 30 general medical practices will be recruited across Wales, randomised in a ratio of 2:1 of intervention versus control who will follow usual care. The workshop will be delivered by a GP educator, and will be adapted iteratively throughout the trial period. Baseline practice characteristics will be collected via questionnaire. We will also collect Primary Care Interval (PCI), Two Week Wait (2WW) referral rate, conversion rate and detection rate at baseline and six months post-randomisation. Participant feedback, researcher reflective notes and economic costings will be collected following each workshop. A process evaluation will assess implementation using an adapted Normalisation Measure Development (NoMAD) questionnaire and qualitative interviews. An economic feasibility analysis will inform a future economic evaluation. Discussion This study will allow us to test and further develop a novel evidenced-based complex intervention aimed at general practice teams to expedite the diagnosis of cancer in primary care. The results from this feasibility study will inform the future design of a full-scale definitive phase III trial.

Interventions

OTHERThinkCancer workshop

The proposed intervention, the ThinkCancer! Workshop, is practice-based and consists of themed sessions for both clinical and non-clinical staff, the co-production of a Cancer Safety Netting Plan (CSNP) and the appointment of a Cancer Safety Netting Champion (CSNC). The workshop aims to raise awareness and increase knowledge around current cancer diagnosis guidance and will be delivered over half a day during GP protected time in the form of face-to-face educational sessions. Sessions will consist of a series of interactive activities exploring existing processes within practices and developing plans for change to implement each component.

Sponsors

Cancer Research Wales
CollaboratorUNKNOWN
North Wales Organisation for Randomised Trials in Health
CollaboratorOTHER
Bangor University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Any practices in Wales are eligible for inclusion.

Exclusion criteria

* As we intend to include a broad group of general medical practices, there are no formal

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of a future definitive trialFrom date of initial expression of interest to participate to end of follow up period (13 months)Number of practices approached, interested in participating, consented and randomised, retention of recruited practices, ability to collect data

Secondary

MeasureTime frameDescription
Two Week Wait referral rateSix months pre-randomisation and six months post-randomisationNumber of two week rate referrals made in a given time period, multiplied by 100000 and divided by the practice list size
Primary Care IntervalSix months pre-randomisation and six months post-randomisationThe time between the date of first presentation and the date of referral

Countries

United Kingdom

Contacts

Primary ContactJessica L Roberts, BSc, PhD
j.l.roberts@bangor.ac.uk01248 383516
Backup ContactStefanie Disbeschl
stefanie.disbeschl@bangor.ac.uk01248 383507

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026